CHU Montpellier — Montpellier, France

Public research footprint of CHU Montpellier, compiled from the ClinicalTrials.gov public registry.

557

Registered studies

218

Active

128

Recruiting now

231

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Diffuse Large B Cell Lymphoma · Chronic Lymphocytic Leukemia · Chronic Kidney Disease (CKD)

Recently updated registry entries

NCT05063565 — TheraSphere With Durvalumab and Tremelimumab for HCC (Active Not Recruiting)
NCT05876754 — An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or… (Active Not Recruiting)
NCT06963827 — A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Montpellier?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.